Arbutin
Arbutin has been studied in 3 papers since 2017: none in people yet, 1 in animals, 1 in cells; 1 in the past year. The research so far is in animals and cells. The newest paper, Dec 14, 2025: “Multi-Omics Analysis Identified ADAM7 as a Biomarker and Therapeutic Target for End-Stage Renal Disease”.
At a glance
The findings reach worms or flies, none yet in people. 1 lab in 1 country; 1 trial, none about aging.
None of its findings points the other way.
- 1 lab in 1 country
- 1 trial, none about aging
- Funders: Jilin Provincial Postdoctoral Science Foundation and 3 more
- Model organisms1
- Cells1
- In silico1
What did lifespan studies of arbutin find?
DrugAgeDrugAge records 1 result from 1 paper: 1 in C. elegans. Average lifespan is the mean or the median, as each paper reports it.
What did studies of arbutin find?
3Studies of arbutin measured 3 outcomes: DAF-16 nuclear localization, reactive oxygen species and lifespan.
DAF-16 nuclear localization
upin worms1
1 study
DAF-16 nuclear localization
upin worms1
Arbutin increases DAF-16 nuclear localization in worms.
“improvement of daf-16 nuclear localization”
Model organisms
Arbutin increases Caenorhabditis elegans longevity and stress resistance
PeerJ
Reactive oxygen species
downin worms1
1 study
Reactive oxygen species
downin worms1
Arbutin decreases reactive oxygen species in worms.
“The underlying molecular mechanism for these effects involves decreased levels of reactive oxygen species (ROS)”
Model organisms
Arbutin increases Caenorhabditis elegans longevity and stress resistance
PeerJ
Lifespan
upin worms1
1 study
Lifespan
upin worms1
Arbutin extends lifespan in worms (optimal concentrations).
“The results demonstrated that optimal concentrations of arbutin could extend lifespan and enhance resistance to oxidative stress.”
Model organismsoptimal concentrations
Arbutin increases Caenorhabditis elegans longevity and stress resistance
PeerJ
Trial sponsors
Company1 trialPhase 2/3110 people